Clinical symptoms of red amanita poisoning: signs and help

Amanita muscaria poisoning symptoms — including nausea, confusion, dizziness, and altered perception — typically appear within 30–90 minutes of ingestion and result primarily from ibotenic acid before conversion to muscimol; severe toxicity is rare but requires medical attention.

What Causes the Symptoms: Ibotenic Acid and Muscimol

Amanita muscaria poisoning has a distinctive profile because it involves two pharmacologically opposite compounds acting in sequence. Ibotenic acid is an excitatory neurotoxin that activates glutamate receptors (NMDA and AMPA subtypes). Its effects are stimulatory: nausea, agitation, confusion, muscle twitching, elevated heart rate. This is the first compound to act after ingestion, and it dominates the early phase of toxicity. Muscimol is an inhibitory compound that acts on GABA-A receptors — the same system targeted by benzodiazepines and alcohol, but through a different binding site. Its effects are sedating and dissociative. As ibotenic acid gradually converts to muscimol in the body, the clinical picture shifts from excitement to sedation. This two-phase pattern — stimulation followed by depression — is what makes Amanita muscaria poisoning clinically distinctive. It also explains why the symptom timeline is more complex than with most other toxic mushrooms. Other active compounds present in smaller quantities include muscazone and muscaridine. Muscarine — often listed in older sources as a primary Amanita muscaria toxin — is actually present in only trace amounts and does not meaningfully contribute to the clinical picture of Amanita muscaria poisoning specifically.

Symptom Timeline: What to Expect and When

Time after ingestion	Phase	Primary symptoms
0–30 min	Latency	Usually none, or mild stomach discomfort
30 min – 2 hrs	Early onset	Nausea, salivation, dizziness, mild agitation
1–4 hrs	Excitement phase	Hallucinations, confusion, motor incoordination, elevated heart rate, flushing
4–8 hrs	Sedation/coma phase	Progressive drowsiness, possible loss of consciousness, deep sleep
8–24 hrs	Recovery	Spontaneous awakening, residual headache, weakness, coordination issues

The total course is typically 12–24 hours. Most people recover fully. The sedation phase can be alarming to observers — the person appears deeply unconscious but can often be roused. This is distinct from the irreversible coma of amatoxin (death cap) poisoning, which represents organ failure rather than deep CNS depression.

The First Phase: Excitement, Hallucinations, and Agitation

The first clinical period begins 1–4 hours after consumption and is driven predominantly by ibotenic acid's excitatory effects. Clinical records from hospital admissions document this phase in detail: The person typically reports a feeling of unusual warmth or heat spreading through the body, followed by tingling sensations and a subjective feeling of lightness. Motor coordination deteriorates — movements become uncoordinated, limb control is unreliable. Dizziness is common. Mental state changes follow: psychomotor agitation, confusion, and in higher-dose cases, visual and auditory hallucinations. The hallucinatory experience associated with Amanita muscaria is typically described as quite different from psilocybin-type experiences — more disorienting, less visually structured, often dreamlike and difficult to distinguish from reality. The excitement phase may include:

• Tachycardia (elevated heart rate)
• Mydriasis (pupil dilation)
• Skin flushing and dryness
• Excessive salivation early, shifting to dry mouth later
• Muscle spasms or twitching
• Heightened blood pressure
• Emotional lability — rapid shifts between anxiety and euphoria

In the hospital case series from the Poznań Department of Toxicology (Łukasik-Głębocka et al., 2011), symptoms appeared after 30 minutes to 2 hours and included vomiting, hallucinations, restlessness, and CNS depression in sequence. Acute respiratory involvement was observed in some cases and represented the most dangerous complication.

The Second Phase: Sedation and Deep Sleep

As muscimol becomes the dominant active compound — either through in vivo conversion of ibotenic acid or because the preparation already contained high muscimol levels — the clinical picture shifts dramatically. The agitation and hallucinations give way to deep sedation. The person becomes progressively drowsy, then falls into a sleep-like state that can deepen into coma. This comatose period typically lasts several hours and resolves spontaneously. During this phase, the person can sometimes be briefly aroused but quickly returns to a deeply unconscious state. From clinical case documentation: patients in this phase have been described as experiencing vivid, dreamlike internal experiences — sometimes described after recovery as a feeling of "reincarnation" or "transition." This is a consistent feature of historical Amanita muscaria accounts across cultures and is now understood as the subjective experience of high-dose muscimol acting on GABA-A receptors in the central nervous system.

Severity Scale: Mild, Moderate, and Severe Cases

Not all Amanita muscaria poisoning episodes are equivalent. Severity depends primarily on dose, the ibotenic acid content of the material consumed (preparation quality), body weight, and individual sensitivity. Mild (most common): Nausea, dizziness, mild confusion, some perceptual changes. The person remains coherent and ambulatory. Self-resolves in 4–8 hours without medical intervention. Moderate: Significant agitation or hallucinations, motor incoordination, vomiting. May require supportive care. The person may not be able to care for themselves during the peak phase. Resolves within 12–24 hours. Severe (rare): Loss of consciousness, respiratory depression, prolonged coma. Requires emergency medical attention. Documented most commonly in cases involving very large quantities of raw or minimally processed material, or in cases involving children (who have lower body weight and different metabolic rates). Research by Satora et al. (2005) documented five young adults who consumed dried Amanita muscaria caps. Four experienced visual and auditory hallucinations. One 18-year-old lost consciousness and was hospitalised for observation. After four days she was discharged without complications. The remaining four had no lasting effects. This case illustrates both the range of individual response and the generally favourable prognosis.

Recovery and Medical Treatment

The treatment for Amanita muscaria poisoning is supportive — there is no specific antidote for ibotenic acid or muscimol. Standard approaches include: Early intervention (within 1–2 hours):

• Activated charcoal administration to reduce further absorption if the person presents promptly
• Gastric lavage in severe cases where large quantities were consumed recently
• Induced vomiting is generally no longer recommended in medical settings due to aspiration risk

Supportive care during acute phase:

• Monitoring of vital signs, particularly respiratory rate and oxygen saturation
• IV fluids if vomiting has caused dehydration
• Calm environment — agitation worsens the stimulatory phase
• Physical restraint only if the person is at risk of self-injury from extreme motor agitation

Atropine is NOT indicated for Amanita muscaria poisoning, despite being used for other types of muscarine-driven mushroom toxicity. Because muscarine is not a significant factor in Amanita muscaria poisoning, atropine provides no benefit and may worsen the anticholinergic-adjacent features of ibotenic acid toxicity. Recovery after the coma phase typically involves residual headache, weakness, and sometimes mild coordination and vision impairment that can persist for several days. Full recovery is the expected outcome in the vast majority of cases.

When to Seek Emergency Care

Most Amanita muscaria poisoning cases are unpleasant but not life-threatening. Seek emergency medical care immediately if:

• The person loses consciousness and cannot be roused
• Breathing is laboured, slow, or irregular
• The person is a child, elderly, or has known heart or respiratory conditions
• Symptoms are worsening after 4 hours rather than stabilising
• You are uncertain about the species — if there is any possibility the person consumed Amanita phalloides (death cap) or Amanita virosa (destroying angel), treat as a medical emergency immediately. These contain amatoxins and cause fatal liver failure. There is no safe observation period for suspected death cap poisoning.

How Amanita muscaria Symptoms Differ From Death Cap Poisoning

The critical clinical distinction: Amanita muscaria symptoms appear within hours and represent acute CNS effects that resolve within 24 hours. Amanita phalloides (death cap) poisoning has a delayed onset of 6–24 hours, a deceptive symptom-free period after initial gastroenteritis, and then progressive organ failure over 3–7 days. If someone presents with gastrointestinal symptoms that appeared 6 hours or more after consuming mushrooms, or if symptoms seemed to improve but then worsen, assume amatoxin poisoning until proven otherwise. Amanita muscaria poisoning does not follow this delayed pattern.

Bottom Line

Amanita muscaria poisoning is characterised by a two-phase course — excitement then sedation — that typically resolves within 24 hours. Severe outcomes are rare and associated with large doses of raw material. Supportive treatment is the standard approach. The key clinical distinction is from amatoxin-containing species: if there is any uncertainty about species identity, treat as a medical emergency.

Related Amanita muscaria products

1. Amanita muscaria Grade A
2. Amanita muscaria Capsules
3. Amanita muscaria Tincture
4. Amanita muscaria Powder

Frequently Asked Questions

How long do Amanita muscaria poisoning symptoms last?

The full course of Amanita muscaria poisoning typically lasts 12–24 hours from onset. The excitement phase (nausea, agitation, hallucinations) peaks around 1–4 hours post-ingestion. The sedation/coma phase follows and may last several hours. Most people wake spontaneously and begin recovery. Residual symptoms — headache, weakness, mild coordination issues — can persist for another 1–2 days. Full recovery is expected in the vast majority of cases, including those involving loss of consciousness.

What is the difference between Amanita muscaria poisoning and death cap poisoning?

They are completely different in mechanism, timeline, and severity. Amanita muscaria poisoning is an acute CNS event driven by ibotenic acid and muscimol, appears within hours, and resolves within 24 hours. Amanita phalloides (death cap) poisoning is driven by amatoxins, has a delayed onset of 6–24 hours, causes progressive liver and kidney failure over 3–7 days, and can be fatal. If there is any doubt about species identification, treat as potential amatoxin poisoning — it's the conservative and correct approach.

Can Amanita muscaria poisoning be fatal?

Documented fatalities from Amanita muscaria specifically are extremely rare. The ibotenic acid content causes significant toxicity at high doses, but the LD50 is high enough that typical cases — even those involving hallucinations and loss of consciousness — resolve without permanent harm. Serious outcomes are associated with very large quantities of raw material or vulnerable populations (children, people with pre-existing cardiac or respiratory conditions). By contrast, a single cap of Amanita phalloides can be fatal.

Should I induce vomiting if someone has eaten Amanita muscaria?

Modern medical guidelines generally advise against inducing vomiting at home — it carries a risk of aspiration, especially if the person is becoming drowsy or confused. Activated charcoal administered early in a medical setting is more effective. If the person is conscious and symptoms are just beginning (within 1 hour), call Poison Control or emergency services immediately for guidance. Do not wait for symptoms to worsen before making that call.

How does Amanita muscaria poisoning feel subjectively?

Based on case reports and firsthand accounts, the experience is distinctly different from psilocybin mushroom effects. The excitement phase involves disorientation, dreamlike hallucinations that are hard to distinguish from reality, and a sense of physical lightness followed by loss of motor control. The sedation phase feels like a very deep dreamlike sleep with vivid internal experiences. Many people describe a feeling of disorientation or "reincarnation" upon waking. The overall experience is generally described as less visually structured and more confusing than classic psychedelic effects.

Related Articles

• Is Amanita Muscaria Poisonous?
• Amanita muscaria Safety Checklist
• Who Should Avoid Amanita Pantherina
• Chemistry of Amanita muscaria: Muscimol and Ibotenic Acid

Sources

1. Michelot D, Melendez-Howell LM. Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycological Research. 2003. PMID 12733432
2. Satora L, et al. Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon. 2005. PMID 15683901
3. Łukasik-Głębocka M, et al. Poisoning with Amanita muscaria and Amanita pantherina. Przegl Lek. 2011. PMID 22232984